CY-09 significantly ameliorates metabolic disorders in a diabetic mouse model (147), and can also alleviate inflammation, oxidative stress, and fibrosis in diabetic mice by selectively inhibiting NLRP3 inflammasome, thereby improving renal damage in diabetic nephropathy (149). This evidence concerns the gene NLRP3 and diabetes mellitus.